{"id":"https://openalex.org/W177130592","doi":"https://doi.org/10.4414/smw.2007.11852","title":"Intravenous ketamine therapy in a patient with a treatment-resistant major depression","display_name":"Intravenous ketamine therapy in a patient with a treatment-resistant major depression","alternate_titles":[],"publication_year":2007,"publication_date":"2007-04-21","ids":{"openalex":"https://openalex.org/W177130592","doi":"https://doi.org/10.4414/smw.2007.11852","mag":"177130592","pmid":"https://pubmed.ncbi.nlm.nih.gov/17525879"},"language":"en","primary_location":{"id":"doi:10.4414/smw.2007.11852","doi":"https://doi.org/10.4414/smw.2007.11852","is_oa":true,"landing_page_url":"https://doi.org/10.4414/smw.2007.11852","pdf_url":null,"source":{"id":"https://openalex.org/S4394736658","display_name":"Swiss Medical Weekly","issn_l":"0036-7672","issn":["0036-7672","1424-3997","1424-7860"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","ddh","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1","vabb-shw"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Swiss Medical Weekly","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W177130592"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.4414/smw.2007.11852","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5045727436","display_name":"Michael Liebrenz","orcid":"https://orcid.org/0000-0001-8040-2744","observed_orcids":["https://orcid.org/0000-0001-8040-2744"]},"institutions":[{"id":"https://openalex.org/I4405262024","display_name":"Psychiatrische Universit\u00e4tsklinik Z\u00fcrich","ror":"https://ror.org/00yt5p853","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4405262024"]}],"countries":["CH"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M Liebrenz","raw_affiliation_strings":["Psychiatric University Hospital, Research Group on Substance Use Disorders, Zurich, Switzerland. Michael.Liebrenz@puk.zh.ch"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatric University Hospital, Research Group on Substance Use Disorders, Zurich, Switzerland. Michael.Liebrenz@puk.zh.ch","institution_ids":["https://openalex.org/I4405262024"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007602489","display_name":"Alain Borgeat","orcid":"https://orcid.org/0000-0002-1509-1537","observed_orcids":["https://orcid.org/0000-0002-1509-1537"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A Borgeat","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039495866","display_name":"Ria Leisinger","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"R Leisinger","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5080995272","display_name":"Rudolf Stohler","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Rudolf Stohler","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.4396,"has_fulltext":false,"cited_by_count":83,"citation_normalized_percentile":{"value":0.91008247,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"137","issue":"1516","first_page":"234","last_page":"236"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11921","display_name":"Electroconvulsive Therapy Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11337","display_name":"Tryptophan and brain disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2803","display_name":"Biological Psychiatry"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ketamine","display_name":"ketamine","score":0.8360000252723694},{"id":"https://openalex.org/keywords/intravenous-infusion","display_name":"intravenous infusion","score":0.8149999976158142},{"id":"https://openalex.org/keywords/treatment-resistant-depression","display_name":"treatment-resistant depression","score":0.9319999814033508},{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":0.9610000252723694},{"id":"https://openalex.org/keywords/substance-use-disorders","display_name":"substance use disorders","score":0.7139999866485596},{"id":"https://openalex.org/keywords/alcoholism","display_name":"alcoholism","score":0.9900000095367432},{"id":"https://openalex.org/keywords/benzodiazepine-dependence","display_name":"benzodiazepine dependence","score":1.0},{"id":"https://openalex.org/keywords/antidepressant-effects","display_name":"antidepressant effects","score":0.6510000228881836},{"id":"https://openalex.org/keywords/rapid-antidepressant-response","display_name":"rapid antidepressant response","score":0.7110000252723694},{"id":"https://openalex.org/keywords/nmda-receptor-antagonist","display_name":"NMDA receptor antagonists","score":0.9660000205039978}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8645220398902893},{"id":"https://openalex.org/C2780795376","wikidata":"https://www.wikidata.org/wiki/Q243547","display_name":"Ketamine","level":2,"score":0.8284647464752197},{"id":"https://openalex.org/C2909081213","wikidata":"https://www.wikidata.org/wiki/Q243547","display_name":"Ketamine hydrochloride","level":3,"score":0.6645660400390625},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.6217448115348816},{"id":"https://openalex.org/C2779631380","wikidata":"https://www.wikidata.org/wiki/Q813655","display_name":"Beck Depression Inventory","level":3,"score":0.6206961274147034},{"id":"https://openalex.org/C2776867660","wikidata":"https://www.wikidata.org/wiki/Q1814941","display_name":"Depression (economics)","level":2,"score":0.6206957101821899},{"id":"https://openalex.org/C2777342061","wikidata":"https://www.wikidata.org/wiki/Q7836891","display_name":"Treatment-resistant depression","level":4,"score":0.5787881016731262},{"id":"https://openalex.org/C2778173252","wikidata":"https://www.wikidata.org/wiki/Q83871","display_name":"Benzodiazepine","level":3,"score":0.5399799942970276},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.5327152609825134},{"id":"https://openalex.org/C83849319","wikidata":"https://www.wikidata.org/wiki/Q7295720","display_name":"Rating scale","level":2,"score":0.46543779969215393},{"id":"https://openalex.org/C2777330709","wikidata":"https://www.wikidata.org/wiki/Q131543","display_name":"Electroconvulsive therapy","level":3,"score":0.443204790353775},{"id":"https://openalex.org/C2776466505","wikidata":"https://www.wikidata.org/wiki/Q385555","display_name":"Hamilton Rating Scale for Depression","level":4,"score":0.42123931646347046},{"id":"https://openalex.org/C2780051608","wikidata":"https://www.wikidata.org/wiki/Q42844","display_name":"Major depressive disorder","level":3,"score":0.386496365070343},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3245752453804016},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2724933624267578},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.08056935667991638},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.05403187870979309},{"id":"https://openalex.org/C139719470","wikidata":"https://www.wikidata.org/wiki/Q39680","display_name":"Macroeconomics","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C2910926394","wikidata":"https://www.wikidata.org/wiki/Q131543","display_name":"Electroconvulsive Shock","level":2,"score":0.0},{"id":"https://openalex.org/C138496976","wikidata":"https://www.wikidata.org/wiki/Q175002","display_name":"Developmental psychology","level":1,"score":0.0},{"id":"https://openalex.org/C169900460","wikidata":"https://www.wikidata.org/wiki/Q2200417","display_name":"Cognition","level":2,"score":0.0},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004351","descriptor_name":"Drug Resistance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007649","descriptor_name":"Ketamine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018691","descriptor_name":"Excitatory Amino Acid Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.4414/smw.2007.11852","doi":"https://doi.org/10.4414/smw.2007.11852","is_oa":true,"landing_page_url":"https://doi.org/10.4414/smw.2007.11852","pdf_url":null,"source":{"id":"https://openalex.org/S4394736658","display_name":"Swiss Medical Weekly","issn_l":"0036-7672","issn":["0036-7672","1424-3997","1424-7860"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","ddh","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1","vabb-shw"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Swiss Medical Weekly","raw_type":"journal-article"},{"id":"pmid:17525879","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17525879","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Swiss medical weekly","raw_type":"Clinical Trial"},{"id":"pmh:oai:doaj.org/article:23596e6b500f4348901f99db3816013d","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/23596e6b500f4348901f99db3816013d","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Swiss Medical Weekly, Vol 137, Iss 1516 (2007)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.4414/smw.2007.11852","doi":"https://doi.org/10.4414/smw.2007.11852","is_oa":true,"landing_page_url":"https://doi.org/10.4414/smw.2007.11852","pdf_url":null,"source":{"id":"https://openalex.org/S4394736658","display_name":"Swiss Medical Weekly","issn_l":"0036-7672","issn":["0036-7672","1424-3997","1424-7860"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","ddh","doaj","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70","russia-white-list-1","vabb-shw"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Swiss Medical Weekly","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":6,"referenced_works":["https://openalex.org/W1936249141","https://openalex.org/W2023081218","https://openalex.org/W2024149525","https://openalex.org/W2080746031","https://openalex.org/W2098750661","https://openalex.org/W2114613490"],"related_works":["https://openalex.org/W2035979548","https://openalex.org/W2472214535","https://openalex.org/W4398225485","https://openalex.org/W3217323340","https://openalex.org/W2572860209","https://openalex.org/W2123488676","https://openalex.org/W2949955873","https://openalex.org/W7133196440","https://openalex.org/W7217201725","https://openalex.org/W3030295226"],"abstract_inverted_index":{"BACKGROUND:":[0],"Recently,":[1],"reports":[2],"from":[3,149,155],"North":[4],"America":[5],"have":[6,187],"indicated":[7],"that":[8],"the":[9,47,99,107,128,132,143,168,177],"intravenous":[10,78],"infusion":[11,79,147,169],"of":[12,26,34,80,87,95,130,138],"ketamine":[13,36,83,131],"hydrochloride":[14],"(an":[15],"N-methyl-d-aspartate":[16],"receptor":[17],"antagonist)":[18],"results":[19],"in":[20,37,50],"a":[21,38,41,51,65,70,85,96,135],"sudden":[22],"and":[23,69,73,106,121,170],"robust":[24],"improvement":[25,137],"depression":[27,68],"symptoms.":[28],"OBJECTIVE:":[29],"To":[30],"corroborate":[31],"antidepressant":[32,189],"effectiveness":[33],"IV":[35],"patient":[39],"with":[40,64],"co-occurring":[42,71],"substance":[43],"use":[44],"disorder":[45],"for":[46],"first":[48,162],"time":[49],"European":[52],"clinical":[53,97],"setting.":[54],"DESIGN:":[55],"Open":[56],"label":[57],"trial":[58],"Methods:":[59],"A":[60],"55-year-old":[61],"male":[62],"subject":[63,133,161],"treatment-resistant":[66],"major":[67],"alcohol":[72,203],"benzodiazepine":[74],"dependence":[75],"received":[76],"an":[77,202],"0.5":[81],"mg/kg":[82],"over":[84],"period":[86],"50":[88],"minutes.":[89],"Effects":[90],"were":[91,199],"assessed":[92],"by":[93,201],"means":[94],"interview,":[98],"21-item":[100,108],"Hamilton":[101],"Depression":[102,110],"Rating":[103],"scale":[104],"(HDRS),":[105],"Beck":[109],"Inventory":[111],"(BDI)":[112],"at":[113],"baseline,":[114],"1":[115,117],"hour,":[116],"day,":[118],"2":[119],"days,":[120],"7":[122,179],"days":[123],"after":[124],"intervention.":[125],"RESULTS:":[126],"Following":[127],"administration":[129],"experienced":[134],"significant":[136],"his":[139],"symptoms":[140],"peaking":[141],"on":[142],"2nd":[144],"day":[145],"post":[146],"(HDRS":[148],"36":[150],"to":[151,157,172,186,193],"16;":[152],"-56.6%,":[153],"BDI":[154],"26":[156],"9;":[158],"-65.4%).":[159],"The":[160],"reported":[163],"improvements":[164],"25":[165],"min.":[166],"into":[167],"continued":[171],"describe":[173],"positive":[174],"effects":[175,190],"throughout":[176],"subsequent":[178],"days.":[180],"CONCLUSION:":[181],"Ketamine":[182],"not":[183],"only":[184],"seems":[185],"strong":[188],"but":[191],"also":[192],"act":[194],"very":[195],"swiftly.":[196],"These":[197],"actions":[198],"unaffected":[200],"or":[204],"benzodiazpine":[205],"dependence.":[206]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W177130592","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":11},{"year":2013,"cited_by_count":9},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
